Judith L. Treadway

Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose <i>in vivo</i>

William H. Martin, Dennis J. Hoover, Sandra J. Armento et al. · Proceedings of the National Academy of Sciences · 1998 · 230 citations · Full text

Glycobiology, Metabolic Remodeling, Experimental Pharmacology +17

Astrocyte Glycogen Sustains Neuronal Activity during Hypoglycemia: Studies with the Glycogen Phosphorylase Inhibitor CP-316,819 ([R-R*,S*]-5-Chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1 H-indole-2-carboxamide)

Sang Won Suh, Jennifer P. Bergher, Christopher M. Anderson et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 177 citations

Inhibitory Effects of Antipsychotics on Carbachol-Enhanced Insulin Secretion From Perifused Rat Islets

David E. Johnson, Hanae Yamazaki, Karen Ward et al. · Diabetes · 2005 · 129 citations · Full text

Human liver glycogen phosphorylase inhibitors bind at a new allosteric site

Virginia L. Rath, Mark Ammirati, Dennis E. Danley et al. · Chemistry & Biology · 2000 · 126 citations · Full text

Biochemistry, Medicine, Liver Physiology +7

Discovery of (<i>S</i>)-6-(3-Cyclopentyl-2-(4-(trifluoromethyl)-1<i>H</i>-imidazol-1-yl)propanamido)nicotinic Acid as a Hepatoselective Glucokinase Activator Clinical Candidate for Treating Type 2 Diabetes Mellitus

Jeffrey A. Pfefferkorn, Angel Guzmán-Pérez, John Litchfield et al. · Journal of Medicinal Chemistry · 2011 · 114 citations · Full text